Dermtest is a digital health startup empowering general practitioners in fighting melanoma, the deadliest type of skin-cancer.
We connect general practitioners with dermoscopists, to provide patients early skin-cancer detection service at their local family doctor's office. The service enables discovering early changes in moles that may develop into malignant skin tumors. We combine teledermatology software and diagnostic hardware into a complete solution. Dermtest increases access, cost-efficiency and early detection rates.
Dermtest started in 2013 as a local telemedicine project for early melanoma detection between 2 GP-offices in rural areas and the largest Dermato-oncology clinic in the capital of Estonia. It was developed in close cooperation with experienced dermato-oncologists – all practicing clinicians. In 2014 Dermtest spinned-off into a start-up for scaling the technology. The system has been presented at the World Congress of Dermoscopy and World Congress of Teledermatology. Dermtest was also nominated for the Digital Health Innovation Award at the Munich Network annual conference. We are also at StartupBootcamp Digital Health in Berlin.
An important milestone was also Horizon2020 SME instrument Phase 1, which gave us a possibility to evaluate the feasibility of the business model and develop it further. We also participated in the Medical Valley bootcamp in Erlangen, Germany and built a network for next steps in the region. The service is operational and growing in Estonia and Lithuania, more than 150 clinicians are using the system regularly, with more than 5500 cases diagnosed.